Fibrosis pulmonar idiopática, tenemos alteranativas / No disponible
Rev. patol. respir
; 19(3): 101-103, jul.-sept. 2016. ilus, graf
Article
in Spanish
| IBECS
| ID: ibc-157182
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Presentamos un paciente con diagnóstico de fibrosis pulmonar idiopática (FPI) de grado moderado, en el que se inicia tratamiento con pirfenidona. Ante los efectos secundarios cutáneos recidivantes, a pesar de correctas medidas preventivas de protección solar, se suspende dicho fármaco y se inicia tratamiento alternativo con nintedanib, con efectos gastrointestinales leves que se controlan con tratamiento sintomático. A los 4 meses se observa mejoría clínica y leve mejoría funcional
ABSTRACT
We present a patient diagnosed with idiopathic pulmonary fibrosis (IPF) of moderate degree, in which treatment is initiated with pirfenidone. Given the recurrent cutaneous side effects, although correct sunscreen preventive measures, the drug is discontinued and alternative treatment begins with nintedanib with mild gastrointestinal effects that are controlled with symptomatic treatment. At 4 months mild clinical improvement and functional improvement is observed
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Pyridones
/
Lung Diseases, Interstitial
/
Idiopathic Pulmonary Fibrosis
Limits:
Humans
/
Male
Language:
Spanish
Journal:
Rev. patol. respir
Year:
2016
Document type:
Article
Institution/Affiliation country:
Complejo Hospitalario Universitario de Albacete/España